States / New Hampshire / HB 513
HB 513 In Committee
relative to affordability and safety of clinician administered drugs.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Nov 16, 2023 · House
Committee Report: Refer for Interim Study 11/08/2023 (Vote 19-0; CC)
Nov 8, 2023 · House
==CANCELLED== Executive Session: 11/15/2023 11:00 am LOB 302-304 HC 42
Oct 17, 2023 · House
==RECESSED== Executive Session: 11/08/2023 01:30 pm LOB 302-304 HC 42
Sep 6, 2023 · House
==RESCHEDULED== Subcommittee Work Session: 09/20/2023 01:15 pm LOB 302-304 HC 36
Aug 30, 2023 · House
==CANCELLED== Subcommittee Work Session: 09/06/2023 01:15 pm LOB 302-304
Mar 15, 2023 · House
Retained in Committee
Mar 8, 2023 · House
Executive Session: 03/15/2023 11:00 am LOB 302-304
Mar 8, 2023 · House
Subcommittee Work Session: 03/15/2023 10:05 am LOB 302-304
Feb 23, 2023 · House
Executive Session: 03/08/2023 01:15 pm LOB 302-304
Feb 23, 2023 · House
Subcommittee Work Session: 03/08/2023 10:00 am LOB 302-304
Feb 9, 2023 · House
Public Hearing: 02/15/2023 02:00 pm LOB 302-304
Feb 3, 2023 · House
==CANCELLED== Public Hearing: 02/07/2023 02:15 pm LOB 210-211
Jan 11, 2023 · House
Introduced (in recess of) 01/05/2023 and referred to Commerce and Consumer Affairs HJ 3 P. 19